| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of
*
Pathology and
Internal Medicine, Division of Pulmonary and Critical Care, University of Michigan Medical School, Ann Arbor, MI 48109; and
Department of Pathology, Veteran Affairs Medical Center, Ann Arbor, MI 48105
Recent studies suggest that monocyte chemoattractant protein-1
(MCP-1) is involved in fibrosis through the regulation of profibrotic
cytokine generation and matrix deposition. Changes in MCP-1, C-C
chemokine receptor 2 (CCR2), procollagen I and III, and TGF ß were
examined in fibroblasts cultured from normal lung and from nonfibrotic
(i.e., Th1-type) and fibrotic (i.e., Th2-type) pulmonary granulomas.
Th2-type fibroblasts generated 2-fold more MCP-1 than similar numbers
of Th1-type or normal fibroblasts after 24 h in culture. Unlike
normal and Th1-type fibroblasts, Th2-type fibroblasts displayed CCR2
mRNA at 24 h after IL-4 treatment. By flow cytometry, CCR2 was
present on 40% of untreated Th2-type fibroblasts, whereas CCR2 was
present on <20% of normal and Th1-type fibroblasts after similar
treatment. IL-4 increased the number of normal fibroblasts with
cell-surface CCR2 but IFN-
-treatment of normal and Th2-type
fibroblasts significantly decreased the numbers of CCR2-positive cells
in both populations. Western blot analysis showed that total CCR2
protein expression was markedly increased in untreated Th2-type
fibroblasts compared with normal and Th1-type fibroblasts. IL-4
treatment enhanced CCR2 protein in Th1- and Th2-type fibroblasts
whereas IFN- treatment augmented CCR2 protein in normal and Th1-type
fibroblasts. All three fibroblast populations exhibited MCP-1-dependent
TGF-ß synthesis, but only normal and Th2-type fibroblasts showed a
MCP-1 requirement for procollagen mRNA expression. Taken together,
these findings suggest that lung fibroblasts are altered in their
expression of MCP-1, TGF-ß, CCR2, and procollagen following their
participation in pulmonary inflammatory processes, and these changes
may be important during fibrosis.
This article has been cited by other articles:
|
|
 |
|
  M. A.M. Willart, H. Jan de Heer, H. Hammad, T. Soullie, K. Deswarte, B. E. Clausen, L. Boon, H. C. Hoogsteden, and B. N. Lambrecht The lung vascular filter as a site of immune induction for T cell responses to large embolic antigen J. Exp. Med., November 11, 2009; (2009) jem.20082401v2. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. W. Younce, A. Azfer, and P. E. Kolattukudy MCP-1 (Monocyte Chemotactic Protein-1)-induced Protein, a Recently Identified Zinc Finger Protein, Induces Adipogenesis in 3T3-L1 Pre-adipocytes without Peroxisome Proliferator-activated Receptor {gamma} J. Biol. Chem., October 2, 2009; 284(40): 27620 - 27628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Joshi, T. Raymond, A. L. Coelho, S. L. Kunkel, and C. M. Hogaboam A systemic granulomatous response to Schistosoma mansoni eggs alters responsiveness of bone marrow-derived macrophages to Toll-like receptor agonists J. Leukoc. Biol., February 1, 2008; 83(2): 314 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. I. Saada, I. V. Pinchuk, C. A. Barrera, P. A. Adegboyega, G. Suarez, R. C. Mifflin, J. F. Di Mari, V. E. Reyes, and D. W. Powell Subepithelial Myofibroblasts are Novel Nonprofessional APCs in the Human Colonic Mucosa J. Immunol., November 1, 2006; 177(9): 5968 - 5979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Beck, B. Tancowny, M. E. Brummet, S. Y. Asaki, S. L. Curry, M. B. Penno, M. Foster, A. Bahl, and C. Stellato Functional Analysis of the Chemokine Receptor CCR3 on Airway Epithelial Cells. J. Immunol., September 1, 2006; 177(5): 3344 - 3354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Henke, C. G. Pearce, D. M. Moaveni, A. J. Moore, E. M. Lynch, C. Longo, M. Varma, N. A. Dewyer, K. B. Deatrick, G. R. Upchurch Jr, et al. Targeted Deletion of CCR2 Impairs Deep Vein Thombosis Resolution in a Mouse Model. J. Immunol., September 1, 2006; 177(5): 3388 - 3397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Baouz, J. Giron-Michel, B. Azzarone, M. Giuliani, F. Cagnoni, S. Olsson, R. Testi, G. Gabbiani, and G. W. Canonica Lung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of {alpha}-SMA and NF-{kappa}B Int. Immunol., November 1, 2005; 17(11): 1473 - 1481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Dewald, P. Zymek, K. Winkelmann, A. Koerting, G. Ren, T. Abou-Khamis, L. H. Michael, B. J. Rollins, M. L. Entman, and N. G. Frangogiannis CCL2/Monocyte Chemoattractant Protein-1 Regulates Inflammatory Responses Critical to Healing Myocardial Infarcts Circ. Res., April 29, 2005; 96(8): 881 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Capelli, A. Di Stefano, I. Gnemmi, and C. F. Donner CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis Eur. Respir. J., April 1, 2005; 25(4): 701 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Watts, E. M. Sampson, G. S. Schultz, and M. A. Spiteri Simvastatin Inhibits Growth Factor Expression and Modulates Profibrogenic Markers in Lung Fibroblasts Am. J. Respir. Cell Mol. Biol., April 1, 2005; 32(4): 290 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Jakubzick, H. Wen, A. Matsukawa, M. Keller, S. L. Kunkel, and C. M. Hogaboam Role of CCR4 Ligands, CCL17 and CCL22, During Schistosoma mansoni Egg-Induced Pulmonary Granuloma Formation in Mice Am. J. Pathol., October 1, 2004; 165(4): 1211 - 1221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Choi, C. Jakubzick, K. J. Carpenter, S. L. Kunkel, H. Evanoff, F. J. Martinez, K. R. Flaherty, G. B. Toews, T. V. Colby, E. A. Kazerooni, et al. Enhanced Monocyte Chemoattractant Protein-3/CC Chemokine Ligand-7 in Usual Interstitial Pneumonia Am. J. Respir. Crit. Care Med., September 1, 2004; 170(5): 508 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kitagawa, T. Wada, K. Furuichi, H. Hashimoto, Y. Ishiwata, M. Asano, M. Takeya, W. A. Kuziel, K. Matsushima, N. Mukaida, et al. Blockade of CCR2 Ameliorates Progressive Fibrosis in Kidney Am. J. Pathol., July 1, 2004; 165(1): 237 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jakubzick, E. S. Choi, K. J. Carpenter, S. L. Kunkel, H. Evanoff, F. J. Martinez, K. R. Flaherty, G. B. Toews, T. V. Colby, W. D. Travis, et al. Human Pulmonary Fibroblasts Exhibit Altered Interleukin-4 and Interleukin-13 Receptor Subunit Expression in Idiopathic Interstitial Pneumonia Am. J. Pathol., June 1, 2004; 164(6): 1989 - 2001. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Jakubzick, E S Choi, S L Kunkel, H Evanoff, F J Martinez, R K Puri, K R Flaherty, G B Toews, T V Colby, E A Kazerooni, et al. Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia J. Clin. Pathol., May 1, 2004; 57(5): 477 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Wada, K. Furuichi, N. Sakai, Y. Iwata, K. Kitagawa, Y. Ishida, T. Kondo, H. Hashimoto, Y. Ishiwata, N. Mukaida, et al. Gene Therapy via Blockade of Monocyte Chemoattractant Protein-1 for Renal Fibrosis J. Am. Soc. Nephrol., April 1, 2004; 15(4): 940 - 948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Hildebrandt, U. A. Duffner, K. M. Olkiewicz, L. A. Corrion, N. E. Willmarth, D. L. Williams, S. G. Clouthier, C. M. Hogaboam, P. R. Reddy, B. B. Moore, et al. A critical role for CCR2/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation Blood, March 15, 2004; 103(6): 2417 - 2426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Santiago, M. Galindo, G. Palao, and J. L. Pablos Intracellular Regulation of Fas-Induced Apoptosis in Human Fibroblasts by Extracellular Factors and Cycloheximide J. Immunol., January 1, 2004; 172(1): 560 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Chen, Y. Wei, G. C. Sharp, and H. Braley-Mullen Mechanisms of Spontaneous Resolution versus Fibrosis in Granulomatous Experimental Autoimmune Thyroiditis J. Immunol., December 1, 2003; 171(11): 6236 - 6243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jakubzick, E. S. Choi, B. H. Joshi, M. P. Keane, S. L. Kunkel, R. K. Puri, and C. M. Hogaboam Therapeutic Attenuation of Pulmonary Fibrosis Via Targeting of IL-4- and IL-13-Responsive Cells J. Immunol., September 1, 2003; 171(5): 2684 - 2693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. W. Lukacs, A. L. Miller, and C. M. Hogaboam Chemokine Receptors in Asthma: Searching for the Correct Immune Targets J. Immunol., July 1, 2003; 171(1): 11 - 15. [Full Text] [PDF]
|
|
|
|
|
|
C. Jakubzick, E. S. Choi, S. L. Kunkel, B. H. Joshi, R. K. Puri, and C. M. Hogaboam Impact of Interleukin-13 Responsiveness on the Synthetic and Proliferative Properties of Th1- and Th2-Type Pulmonary Granuloma Fibroblasts Am. J. Pathol., May 1, 2003; 162(5): 1475 - 1486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jakubzick, S. L. Kunkel, B. H. Joshi, R. K. Puri, and C. M. Hogaboam Interleukin-13 Fusion Cytotoxin Arrests Schistosoma mansoni Egg-Induced Pulmonary Granuloma Formation in Mice Am. J. Pathol., October 1, 2002; 161(4): 1283 - 1297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. G. Luzina, S. P. Atamas, R. Wise, F. M. Wigley, H. Q. Xiao, and B. White Gene Expression in Bronchoalveolar Lavage Cells from Scleroderma Patients Am. J. Respir. Cell Mol. Biol., May 1, 2002; 26(5): 549 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gauldie Inflammatory Mechanisms Are a Minor Component of the Pathogenesis of Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., May 1, 2002; 165(9): 1205 - 1206. [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Hubbard, C. R. Timblin, A. Shukla, M. Rincon, and B. T. Mossman Activation of NF-kappa B-dependent gene expression by silica in lungs of luciferase reporter mice Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L968 - L975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhu, B. Ma, T. Zheng, R. J. Homer, C. G. Lee, I. F. Charo, P. Noble, and J. A. Elias IL-13-Induced Chemokine Responses in the Lung: Role of CCR2 in the Pathogenesis of IL-13-Induced Inflammation and Remodeling J. Immunol., March 15, 2002; 168(6): 2953 - 2962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang, L. L. McCormick, S. R. Desai, C. Wu, and A. C. Gilliam Murine Sclerodermatous Graft-Versus-Host Disease, a Model for Human Scleroderma: Cutaneous Cytokines, Chemokines, and Immune Cell Activation J. Immunol., March 15, 2002; 168(6): 3088 - 3098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Bone-Larson, C. M. Hogaboam, H. Evanhoff, R. M. Strieter, and S. L. Kunkel IFN-{gamma}-Inducible Protein-10 (CXCL10) Is Hepatoprotective During Acute Liver Injury Through the Induction of CXCR2 on Hepatocytes J. Immunol., December 15, 2001; 167(12): 7077 - 7083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. O. Yarovinsky and G. W. Hunninghake Lung fibroblasts inhibit activation-induced death of T cells through PGE2-dependent mechanisms Am J Physiol Lung Cell Mol Physiol, November 1, 2001; 281(5): L1248 - L1256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Cazes, J. Giron-Michel, S. Baouz, C. Doucet, F. Cagnoni, S. Oddera, M. Korner, G. Dasic, R. Testi, B. Azzarone, et al. Novel Anti-inflammatory Effects of the Inhaled Corticosteroid Fluticasone Propionate During Lung Myofibroblastic Differentiation J. Immunol., November 1, 2001; 167(9): 5329 - 5337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. B. Moore, R. Paine III, P. J. Christensen, T. A. Moore, S. Sitterding, R. Ngan, C. A. Wilke, W. A. Kuziel, and G. B. Toews Protection from Pulmonary Fibrosis in the Absence of CCR2 Signaling J. Immunol., October 15, 2001; 167(8): 4368 - 4377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. P. Jones, L. M. Hodge, K. Fujihashi, H. Kiyono, J. R. McGhee, and J. W. Simecka The Pulmonary Environment Promotes Th2 Cell Responses After Nasal-Pulmonary Immunization with Antigen Alone, but Th1 Responses Are Induced During Instances of Intense Immune Stimulation J. Immunol., October 15, 2001; 167(8): 4518 - 4526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Tekkanat, H. Maassab, A. A. Berlin, P. M. Lincoln, H. L. Evanoff, M. H. Kaplan, and N. W. Lukacs Role of Interleukin-12 and Stat-4 in the Regulation of Airway Inflammation and Hyperreactivity in Respiratory Syncytial Virus Infection Am. J. Pathol., August 1, 2001; 159(2): 631 - 638. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. M. Strieter Mechanisms of Pulmonary Fibrosis : Conference Summary Chest, July 1, 2001; 120 (2009): 77S - 85S. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yamagami, T. Matsumoto, N. Fujiwara, T. Arakawa, K. Kaneda, I. Yano, and K. Kobayashi Trehalose 6,6'-Dimycolate (Cord Factor) of Mycobacterium tuberculosis Induces Foreign-Body- and Hypersensitivity-Type Granulomas in Mice Infect. Immun., February 1, 2001; 69(2): 810 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Trifilieff, Y. Fujitani, F. Mentz, B. Dugas, M. Fuentes, and C. Bertrand Inducible Nitric Oxide Synthase Inhibitors Suppress Airway Inflammation in Mice Through Down-Regulation of Chemokine Expression J. Immunol., August 1, 2000; 165(3): 1526 - 1533. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
